Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Non-cash Items: 2021-2025

Historic Non-cash Items for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Sep 2025 value amounting to $6.6 million.

  • Kiniksa Pharmaceuticals International's Non-cash Items fell 12.67% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year decrease of 12.67%. This contributed to the annual value of $7.7 million for FY2024, which is 85.96% down from last year.
  • Latest data reveals that Kiniksa Pharmaceuticals International reported Non-cash Items of $6.6 million as of Q3 2025, which was down 8.00% from $7.2 million recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Non-cash Items ranged from a high of $54.7 million in Q4 2023 and a low of $4.4 million during Q1 2021.
  • For the 3-year period, Kiniksa Pharmaceuticals International's Non-cash Items averaged around $11.5 million, with its median value being $7.5 million (2024).
  • In the last 5 years, Kiniksa Pharmaceuticals International's Non-cash Items surged by 118.33% in 2022 and then tumbled by 85.96% in 2024.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Non-cash Items (Quarterly) stood at $14.9 million in 2021, then soared by 118.33% to $32.6 million in 2022, then soared by 67.47% to $54.7 million in 2023, then slumped by 85.96% to $7.7 million in 2024, then fell by 12.67% to $6.6 million in 2025.
  • Its Non-cash Items stands at $6.6 million for Q3 2025, versus $7.2 million for Q2 2025 and $7.8 million for Q1 2025.